CatalystWireBeta

Nuformix

NFX · Main Market · Health Care · mcap £3.6m · 0.1p

Beta Briefing, track record and bull & bear case are not ready for Nuformix yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 44 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Mar 26
Source: results 28 May 26 ↗
Revenue
£0k
Operating profit
−£630k
Net income
−£622k
Free cash flow
−£619k
Net cash
£930k
Market cap
£3.3m
EV / EBIT
–
FCF yield
−19.0%
Price / book
2.0×
Latest half-year · H1 Mar 26 vs H1 Mar 25 results 28 May 26 ↗
Revenue
£0k
prior £0k
Operating profit
−£347k
prior −£377k
Net income
−£347k
prior −£377k
Cash from operations
−£395k
prior −£391k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Latest report: H1 Mar 26 (six months to 31 Mar 26), published 28 May 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

LTM Mar 26FY Sep 25FY Sep 24
Revenue 0.00.0–
Gross profit –0.00.0
Exceptional / adjusting items –0.0(3.1)
Operating profit (0.6)(0.7)(3.6)
Amortisation 0.00.00.0
Profit before tax (0.6)(0.7)(3.6)
Tax 0.00.00.0
Net income (owners) (0.6)(0.7)(3.6)
EPS basic (0.0p)(0.0p)(0.5p)
EPS diluted (0.0p)(0.0p)(0.5p)

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note